Artificial Intelligence

The Oncology Institute promotes new CIO and CPO, signaling a strategic push into AI-driven care and robust talent management to dominate the market.

With the appointment of Dr. Stephen Eck, Flare Therapeutics signals a major push to advance its first-in-class cancer therapies targeting transcription factors.

With record revenue and a bold AI strategy, Opera heads to a key investor conference. Can its 'agentic' browsers redefine the web and win market share?

A new study reveals the hidden quality-of-life toll of a common virus on transplant patients, highlighting the urgent need for targeted new therapies.

Biocytogen and Acepodia are expanding their partnership to create next-gen ADCs with two targets and two warheads, aiming to defeat drug-resistant cancers.

With new funding and a veteran biotech leader, Montreal's Find Therapeutics advances its first-in-class therapy aimed at reversing nerve damage in MS.

An expanded partnership aims to create next-gen cancer therapies by combining bispecific antibodies with two distinct drugs to overcome tumor resistance.

The biotech firm lands a major private placement, extending its cash runway to 2028 and signaling strong investor confidence in its novel drug platform.

Major insurers now cover advanced AI plaque analysis, paving the way for personalized heart attack prevention and a new standard of cardiovascular care.

Predis.ai's new AI promises to slash video ad costs and production time, empowering small businesses and challenging traditional marketing workflows.

Brookfield Asset Management renews its major share buyback plan, a strategic signal of confidence aimed at boosting shareholder value amid market shifts.

A new partnership integrates Lilly's powerful TuneLab AI into Schrödinger's LiveDesign, promising to accelerate R&D with a novel privacy-first approach.

Sanofi deepens its AI partnership with CytoReason in a $16M deal, signaling a major shift in using predictive models to accelerate immunology breakthroughs.

Ocugen heads to a top investor conference with a bold plan for its gene-agnostic therapy, aiming to treat blindness and secure its future in a crowded market.

The institutional crypto exchange reported a sharp decline in spot trading for December, but a massive surge in options volume points to a maturing market.

The acquisition combines autonomous ship platforms with advanced AI, creating an end-to-end solution aimed at dominating the future of maritime defense.

ChipMOS reports stunning 20.8% Q4 growth, highlighting a memory chip frenzy fueled by AI and datacenters. Is this the start of a new tech supercycle?

From a $2.3B real estate privatization to blockbuster retail earnings and a shifting job market, key corporate moves reveal a nation at a crossroads.

With dual robotic arms and AI radar, Dreame's award-winning X-Wind AC offers personalized airflow, signaling a new era for intelligent home technology.

A massive 20-year pact between Meta and Vistra will revive three nuclear plants, adding new carbon-free power to fuel the AI and data center revolution.